CPID 6: ACUTE PRE-B LYMPHOBLASTIC LEUKAEMIA IN A PATIENT WITH X-LINKED AGAMMAGLOBULINEMIA.

Autor: Pumar, M, Fong, CY, Aui, PM, van Zelm, MC, Bosco, J

Publikováno v: Internal Medicine Journal; Sep2017 Supplement S5, Vol. 47, p39-39, 39p

Subcutaneous immunotherapy for bee venom allergy induces epitope spreading and immunophenotypic changes in allergen-specific memory B cells.

Autor: McKenzie CI; Department of Immunology, School of Translational Medicine, Monash University, Melbourne, Australia., Reinwald S; Department of Immunology, School of Translational Medicine, Monash University, Melbourne, Australia; Allergy, Asthma and Clinical Immunology, Alfred Health, Melbourne, Australia., Averso B; EVQLV, New York, NY., Spurrier B; EVQLV, New York, NY., Satz A; EVQLV, New York, NY., von Borstel A; Department of Immunology, School of Translational Medicine, Monash University, Melbourne, Australia., Masinovic S; Department of Immunology, School of Translational Medicine, Monash University, Melbourne, Australia., Varese N; Department of Immunology, School of Translational Medicine, Monash University, Melbourne, Australia; Allergy, Asthma and Clinical Immunology, Alfred Health, Melbourne, Australia; Immune Therapies Group, Burnet Institute, Melbourne, Australia., Aui PM; Department of Immunology, School of Translational Medicine, Monash University, Melbourne, Australia., Wines BD; Immune Therapies Group, Burnet Institute, Melbourne, Australia., Hogarth PM; Department of Immunology, School of Translational Medicine, Monash University, Melbourne, Australia; Immune Therapies Group, Burnet Institute, Melbourne, Australia; Department of Pathology, The University of Melbourne, Parkville, Australia., Hew M; Allergy, Asthma and Clinical Immunology, Alfred Health, Melbourne, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia., Rolland JM; Department of Immunology, School of Translational Medicine, Monash University, Melbourne, Australia; Allergy, Asthma and Clinical Immunology, Alfred Health, Melbourne, Australia., O'Hehir RE; Department of Immunology, School of Translational Medicine, Monash University, Melbourne, Australia; Allergy, Asthma and Clinical Immunology, Alfred Health, Melbourne, Australia., van Zelm MC; Department of Immunology, School of Translational Medicine, Monash University, Melbourne, Australia; Allergy, Asthma and Clinical Immunology, Alfred Health, Melbourne, Australia; Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands. Electronic address: m.vanzelm@erasmusmc.nl.

Publikováno v: The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2024 Aug 30. Date of Electronic Publication: 2024 Aug 30.

RNA sequencing of single allergen-specific memory B cells after grass pollen immunotherapy: Two unique cell fates and CD29 as a biomarker for treatment effect.

Autor: McKenzie CI; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, Victoria, Australia., Varese N; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, Victoria, Australia.; Department of Allergy, Immunology and Respiratory Medicine, Central Clinical School, Monash University, Melbourne, Victoria, Australia., Aui PM; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, Victoria, Australia., Reinwald S; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, Victoria, Australia.; Department of Allergy, Immunology and Respiratory Medicine, Central Clinical School, Monash University, Melbourne, Victoria, Australia., Wines BD; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, Victoria, Australia.; Immune Therapies Group, Burnet Institute, Melbourne, Victoria, Australia.; Department of Pathology, The University of Melbourne, Parkville, Victoria, Australia., Hogarth PM; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, Victoria, Australia.; Immune Therapies Group, Burnet Institute, Melbourne, Victoria, Australia.; Department of Pathology, The University of Melbourne, Parkville, Victoria, Australia., Thien F; Respiratory Medicine, Eastern Health, Box Hill and Monash University, Melbourne, Victoria, Australia., Hew M; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.; Allergy, Asthma and Clinical Immunology, Alfred Health, Melbourne, Victoria, Australia., Rolland JM; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, Victoria, Australia.; Department of Allergy, Immunology and Respiratory Medicine, Central Clinical School, Monash University, Melbourne, Victoria, Australia., O'Hehir RE; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, Victoria, Australia.; Department of Allergy, Immunology and Respiratory Medicine, Central Clinical School, Monash University, Melbourne, Victoria, Australia.; Allergy, Asthma and Clinical Immunology, Alfred Health, Melbourne, Victoria, Australia., van Zelm MC; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, Victoria, Australia.; Allergy, Asthma and Clinical Immunology, Alfred Health, Melbourne, Victoria, Australia.

Publikováno v: Allergy [Allergy] 2023 Mar; Vol. 78 (3), pp. 822-835. Date of Electronic Publication: 2022 Oct 01.

Standardization of Workflow and Flow Cytometry Panels for Quantitative Expression Profiling of Surface Antigens on Blood Leukocyte Subsets: An HCDM CDMaps Initiative.

Autor: Kužílková D; Childhood Leukaemia Investigation Prague (CLIP), Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University, Prague, Czech Republic and University Hospital Motol, Prague, Czechia., Puñet-Ortiz J; Department of Biomedical Sciences, University of Barcelona, Barcelona, Spain., Aui PM; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, VIC, Australia., Fernández J; Department of Biomedical Sciences, University of Barcelona, Barcelona, Spain., Fišer K; Childhood Leukaemia Investigation Prague (CLIP), Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University, Prague, Czech Republic and University Hospital Motol, Prague, Czechia., Engel P; Department of Biomedical Sciences, University of Barcelona, Barcelona, Spain., van Zelm MC; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, VIC, Australia.; Department of Allergy, Immunology and Respiratory Medicine, Central Clinical School, Monash University and Alfred Hospital, Melbourne, VIC, Australia., Kalina T; Childhood Leukaemia Investigation Prague (CLIP), Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University, Prague, Czech Republic and University Hospital Motol, Prague, Czechia.

Publikováno v: Frontiers in immunology [Front Immunol] 2022 Feb 11; Vol. 13, pp. 827898. Date of Electronic Publication: 2022 Feb 11 (Print Publication: 2022).

B-cells expressing NgR1 and NgR3 are localized to EAE-induced inflammatory infiltrates and are stimulated by BAFF.

Autor: Bakhuraysah MM; Department of Neuroscience, Central Clinical School, Monash University, Prahran, VIC, 3004, Australia.; Faculty of Applied Medical Sciences, Taif University, Taif, 26521, Kingdom of Saudi Arabia., Theotokis P; Laboratory of Experimental Neurology and Neuroimmunology, Department of Neurology, AHEPA University Hospital, 54636, Thessaloniki, Macedonia, Greece., Lee JY; Department of Neuroscience, Central Clinical School, Monash University, Prahran, VIC, 3004, Australia.; Toolgen Inc., Gasan Digital-Ro, 08594, Geumcheon, Seoul, Korea., Alrehaili AA; Department of Neuroscience, Central Clinical School, Monash University, Prahran, VIC, 3004, Australia.; Faculty of Applied Medical Sciences, Taif University, Taif, 26521, Kingdom of Saudi Arabia., Aui PM; Department of Neuroscience, Central Clinical School, Monash University, Prahran, VIC, 3004, Australia., Figgett WA; Department of Microbiology and Immunology, School of Biomedical Science, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, 3000, Australia., Azari MF; Department of Neuroscience, Central Clinical School, Monash University, Prahran, VIC, 3004, Australia., Abou-Afech JP; Department of Neuroscience, Central Clinical School, Monash University, Prahran, VIC, 3004, Australia., Mackay F; Department of Microbiology and Immunology, School of Biomedical Science, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, 3000, Australia.; QIMR Berghofer Medical Research Institute, Herston, QLD, 4006, Australia., Siatskas C; STEMCELL Technologies, Vancouver, BC, V6A 1B6, Canada., Alderuccio F; Department of Immunology and Pathology, Central Clinical School, Monash University, Prahran, VIC, 3004, Australia., Strittmatter SM; Program in Cellular Neuroscience, Neurodegeneration and Repair, Yale University School of Medicine, New Haven, CT, 06536, USA., Grigoriadis N; Laboratory of Experimental Neurology and Neuroimmunology, Department of Neurology, AHEPA University Hospital, 54636, Thessaloniki, Macedonia, Greece., Petratos S; Department of Neuroscience, Central Clinical School, Monash University, Prahran, VIC, 3004, Australia. steven.petratos@monash.edu.

Publikováno v: Scientific reports [Sci Rep] 2021 Feb 03; Vol. 11 (1), pp. 2890. Date of Electronic Publication: 2021 Feb 03.